Relay Therapeutics, Inc. (RLAY)
9.18
+0.24
(+2.68%)
USD |
NASDAQ |
Feb 24, 16:00
9.22
+0.04
(+0.44%)
Pre-Market: 08:52
Relay Therapeutics Research and Development Expense (Quarterly) : 68.26M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Celcuity, Inc. | 34.92M |
| Prelude Therapeutics, Inc. | 21.71M |
| Immunome, Inc. | 49.19M |
| ImmunityBio, Inc. | 63.36M |